Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

1.20
-0.1100-8.40%
Post-market: 1.20-0.0019-0.16%19:36 EDT
Volume:1.69M
Turnover:2.07M
Market Cap:92.29M
PE:-0.30
High:1.31
Open:1.28
Low:1.18
Close:1.31
52wk High:5.69
52wk Low:0.9337
Shares:76.90M
Float Shares:56.51M
Volume Ratio:0.53
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.64%
PB:-0.17
PE(LYR):-0.08

Loading ...

Accendra Health Q1 revenue falls, misses estimates

Reuters
·
May 11

Accendra Health Q1 Adj. EPS $(0.04) Beats $(0.10) Estimate, Sales $627.800M Miss $644.636M Estimate

Benzinga Earnings
·
May 11

Accendra Q1 FY26 net loss widens to $6.5 million; net revenue falls to $627.8 million

Reuters
·
May 11

BRIEF-Accendra Health, Inc Q1 Adjusted EBITDA USD 58.4 Million Vs. IBES Estimate USD 57.7 Million

Reuters
·
May 11

Accendra Health Inc - Announces Over $1.5 Bln Balance Sheet Optimization Deal

THOMSON REUTERS
·
May 11

Accendra Health Inc - Affirms Prior Guidance for Net Revenue and Adj Ebitda for Full Year 2026

THOMSON REUTERS
·
May 11

Accendra Health Inc - Deal to Pay off 2027 Maturities and Extend Revolving Credit Facility

THOMSON REUTERS
·
May 11

Accendra Health, Inc Q1 Revenue USD 627.8 Million VS. Ibes Estimate USD 644.6 Million

THOMSON REUTERS
·
May 11

Press Release: Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Dow Jones
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Accendra Health Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

First refunds of Trump tariffs to start as early as May 12, customs agency says

Bloomberg
·
May 05

Accendra Health Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
May 04

Accendra Health sets first-quarter earnings release, investor call

Reuters
·
May 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 01

New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia

GlobeNewswire
·
Apr 08

BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz

Benzinga
·
Mar 11

Press Release: Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Dow Jones
·
Mar 03